Hepatitis A infection and primary hepatocellular carcinoma.

Drucker, J A; Coursaget, P; Maupas, P; Goudeau, A; Gerety, R J; Chiron, J P; Denis, F; Diop Mar, I

Drucker, J A; Coursaget, P; Maupas, P; Goudeau, A; Gerety, R J; Chiron, J P; Denis, F; Diop Mar, I.

Biomedicine ; 31(1): 23-5, 1979 Feb.

Article en En | MEDLINE | ID: mdl-224967

ABSTRACT

ABSTRACT

The prevalence of antibody to the hepatitis A antigen (anti-HAV) has been studied in Senegal, among patients suffering from primary hepatocellular carcinoma (PHC) and among healthy blood donors. Anti-HAV was found in 62.5% of 64 cases of PHC as compared to 64% of 50 blood donors. Anti-HAV was as prevalent among PHC patients who evidenced chronic hepatitis B infection as among those without markers of chronic hepatitis B infection. These data suggest that hepatitis A infection is not associated with PHC in Senegal.

Asunto(s)

Anticuerpos Antivirales/análisis; Carcinoma Hepatocelular/etiología; Hepatitis A/complicaciones; Neoplasias Hepáticas/etiología; Adulto; Carcinoma Hepatocelular/inmunología; Femenino; Hepatitis A/inmunología; Hepatitis B/inmunología; Humanos; Neoplasias Hepáticas/inmunología; Masculino; Senegal

Buscar en Google

Imprimir

XML

PubMed Links

Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Hepatitis A / Neoplasias Hepáticas / Anticuerpos Antivirales Tipo de estudio: Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: Biomedicine Año: 1979 Tipo del documento: Article

Buscar en Google

Imprimir

XML

PubMed Links